Julie Vose, MD, MBA

University of Nebraska Medical Center

Latest Content

Bispecifics, BTK inhibitors, and immunotherapy advances in lymphoma treatment, featuring experts Dr. Rahul Gosain, Dr. Julie Vose, and Dr. Rohit Gosain at OncUpdates conference.

Lymphoma

02/26/2026

Bispecifics, BTK Inhibitors, and Immunotherapy Drive Lymphoma Advances

Julie Vose, MD, MBARahul Gosain, MD, MBARohit Gosain, MD